CALCATERRA, ILENIA LORENZA
 Distribuzione geografica
Continente #
AS - Asia 2.282
NA - Nord America 1.867
EU - Europa 1.388
SA - Sud America 247
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 47
OC - Oceania 1
Totale 5.927
Nazione #
US - Stati Uniti d'America 1.793
SG - Singapore 954
RU - Federazione Russa 632
CN - Cina 454
IT - Italia 384
VN - Vietnam 375
BR - Brasile 176
HK - Hong Kong 162
FR - Francia 83
BD - Bangladesh 82
DE - Germania 80
IN - India 56
JP - Giappone 51
GB - Regno Unito 45
KR - Corea 37
CA - Canada 35
FI - Finlandia 34
NL - Olanda 31
MX - Messico 25
AR - Argentina 23
UA - Ucraina 18
ID - Indonesia 17
ZA - Sudafrica 16
AT - Austria 15
TH - Thailandia 15
EC - Ecuador 13
CI - Costa d'Avorio 11
IQ - Iraq 11
PH - Filippine 9
PL - Polonia 9
TW - Taiwan 9
VE - Venezuela 9
CO - Colombia 8
PK - Pakistan 8
ES - Italia 7
IE - Irlanda 7
PY - Paraguay 7
SE - Svezia 7
DZ - Algeria 6
GR - Grecia 6
TR - Turchia 6
CH - Svizzera 5
JO - Giordania 5
LT - Lituania 5
BO - Bolivia 4
JM - Giamaica 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BE - Belgio 3
KE - Kenya 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
OM - Oman 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NA - Namibia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SO - Somalia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
YE - Yemen 1
Totale 5.835
Città #
Singapore 487
San Jose 316
Ashburn 221
Hefei 171
Hong Kong 157
Moscow 140
Ho Chi Minh City 133
Chandler 114
Beijing 98
Santa Clara 89
Naples 88
Hanoi 84
Los Angeles 54
Lauterbourg 50
Boardman 43
Tokyo 43
Dallas 42
Millbury 37
The Dalles 37
Buffalo 34
New York 33
Seoul 30
Lawrence 29
Des Moines 23
Council Bluffs 21
Munich 19
Milan 18
Amsterdam 17
Helsinki 17
Redondo Beach 17
Orem 16
Frankfurt am Main 15
Haiphong 15
Seattle 15
Da Nang 14
Napoli 14
São Paulo 14
Boston 12
Nuremberg 12
Turku 12
Denver 10
Castel Volturno 9
Houston 9
Hải Dương 9
Montreal 9
Pune 9
Rio de Janeiro 9
Washington 9
Düsseldorf 8
Portsmouth 8
Rome 8
San Francisco 8
Sorrento 8
Toronto 8
Wilmington 8
Atlanta 7
Brooklyn 7
Chennai 7
Shanghai 7
Stockholm 7
Warsaw 7
Belo Horizonte 6
Bologna 6
Changsha 6
Mexico City 6
Woodbridge 6
Xi'an 6
Baghdad 5
Biên Hòa 5
Falkenstein 5
Florence 5
Formia 5
London 5
Manchester 5
Marsala 5
Ottawa 5
Palermo 5
Turin 5
Zurich 5
Afragola 4
Amman 4
Asunción 4
Belvedere Marittimo 4
Brasília 4
Can Tho 4
Curitiba 4
Dhaka 4
Dublin 4
Ercolano 4
Fairfield 4
Guayaquil 4
Johannesburg 4
Lappeenranta 4
Mumbai 4
Nanjing 4
New Delhi 4
Quito 4
Tashkent 4
Thái Bình 4
Vienna 4
Totale 3.152
Nome #
Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: A systematic review with meta-analysis.: VTE recurrence and D-dimer 245
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 156
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 151
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 149
Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia 147
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 142
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 141
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 137
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 134
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 131
Carotid Atherosclerosis, Ultrasound and Lipoproteins 131
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 131
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 130
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 127
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 125
Clinical assessment of endothelial function in heart failure with preserved ejection fraction: A meta-analysis with meta-regressions 125
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 124
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 123
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 123
Clinical assessment of endothelial function in convalescent covid-19 patients undergoing multidisciplinary pulmonary rehabilitation 122
Treatment with pcsk9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: A combined metabolomic and lipidomic approach 122
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 120
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 118
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 117
An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab 117
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 116
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 116
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 115
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 113
Vascular effects of the polyphenolic nutraceutical supplement taurisolo®: Focus on the protection of the endothelial function 112
Persistent endothelial dysfunction in post-acute covid-19 syndrome: A case-control study 110
Risk assessment and antithrombotic strategies in antiphospholipid antibody carriers 109
Homozygous Familial Hypercholesterolemia in Campania 103
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies 102
Post-Bariatric Hypoglycemia Is Associated with Endothelial Dysfunction and Increased Oxidative Stress 102
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies 101
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 95
Alirocumab in high cardiovascular risk patients with Heterozygous Familial Hypercholesterolemia: Efficacy and safety in lipid lowering levels 83
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies 82
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target 81
Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study 80
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model 79
SHORT-TERM VARIABILITY OF 24-H SYSTOLIC BLOOD PRESSURE IS ASSOCIATED WITH MICROALBUMINURIA IN PATIENTS WITH PRIMARY HYPERTENSION 76
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis 75
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions 74
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter study 73
Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials 66
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art 66
Metabolic syndrome in hypertensive patients: An unholy alliance 64
Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients 64
Effects of Mediterranean Diet on Endothelial Reactivity in Individuals with High Cardiometabolic Risk: A Randomized Controlled Parallel-Group Preliminary Trial 63
Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension 58
Acquired Hemophilia A in a Case of Relapsed Immune Thrombotic Thrombocytopenic Purpura 47
Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease 42
Genetic Assessment and Clinical Correlates in Severe Hypertriglyceridemia: A Systematic Review 23
Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A 15
A Rare Case of Acquired Non-neutralizing Factor II Inhibitor in a Patient with B-Cell Lymphoproliferative Disorder. 10
A delayed diagnosis of familial chylomicronemia syndrome in an elderly patient: Clinical implications of late-onset disease 9
Preferences Among Expert Physicians in Areas of Uncertainty in Venous Thromboembolism Management: Results from a Multiple-Choice Questionnaire. 6
Evaluation of surgical stress after colorectal interventions: a multicenter randomized clinical trial of robotic versus laparoscopic surgery 5
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis 4
Totale 5.927
Categoria #
all - tutte 18.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022231 0 7 7 0 11 11 1 7 3 22 92 70
2022/2023267 30 19 11 8 39 33 3 40 38 17 18 11
2023/2024306 22 35 19 19 18 65 3 22 2 6 28 67
2024/20251.570 58 54 37 69 23 122 149 103 78 193 551 133
2025/20263.211 318 295 349 291 503 96 329 161 393 239 92 145
2026/2027248 198 50 0 0 0 0 0 0 0 0 0 0
Totale 5.927